BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19619258)

  • 21. [Analysis of coagulation related parameters between patients with advanced schistosomiasis cirrhosis and hepatitis B cirrhosis].
    Shun L; Meng Q; Shao-Qian T
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2016 Nov; 29(1):68-71. PubMed ID: 29469390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study.
    Lancellotti S; Basso M; Veca V; Sacco M; Riccardi L; Pompili M; De Cristofaro R
    Intern Emerg Med; 2016 Oct; 11(7):959-67. PubMed ID: 27220954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation in Patients With Cirrhosis: Caught Between a Rock-Liver and a Hard Place.
    Ha NB; Regal RE
    Ann Pharmacother; 2016 May; 50(5):402-9. PubMed ID: 26861989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation.
    Gayowski TJ; Marino IR; Doyle HR; Echeverri L; Mieles L; Todo S; Wagener M; Singh N; Yu VL; Fung JJ; Starzl TE
    J Surg Res; 1996 Feb; 60(2):333-8. PubMed ID: 8598664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AGA Clinical Practice Update: Coagulation in Cirrhosis.
    O'Leary JG; Greenberg CS; Patton HM; Caldwell SH
    Gastroenterology; 2019 Jul; 157(1):34-43.e1. PubMed ID: 30986390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procoagulant imbalance aggravated with falling liver function reserve, but not associated with the presence of portal vein thrombosis in cirrhosis.
    Tang W; Wang Y; Zhao X; Wang X; Zhang T; Ou X; Shou W; You H; Jia J
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):672-8. PubMed ID: 25923942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-mode and contrast enhanced ultrasound guided biopsy of portal vein thrombosis. Value in the diagnosis of occult hepatocellular carcinoma in liver cirrhosis.
    Sparchez Z; Radu P; Zaharia T; Kacso G; Diaconu B; Grigorescu I; Badea R
    Med Ultrason; 2010 Dec; 12(4):286-94. PubMed ID: 21210013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis.
    Romero Gómez M; Suárez García E; López Lacomba D; Marchante I; Grande L; Castro Fernandez M
    J Clin Gastroenterol; 2000 Oct; 31(3):237-40. PubMed ID: 11034005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients.
    Zampino R; Lebano R; Coppola N; Macera M; Grandone A; Rinaldi L; De Sio I; Tufano A; Stornaiuolo G; Adinolfi LE; Durante-Mangoni E; Battista GG; Niglio A
    Saudi J Gastroenterol; 2018; 24(1):25-29. PubMed ID: 29451181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability.
    Wosiewicz P; Żorniak M; Hartleb M; Barański K; Hartleb M; Onyszczuk M; Pilch-Kowalczyk J; Kyrcz-Krzemień S
    Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):722-729. PubMed ID: 27160816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients.
    Hayashi T; Takatori H; Horii R; Nio K; Terashima T; Iida N; Kitahara M; Shimakami T; Arai K; Kitamura K; Kawaguchi K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Toyama T; Okumura K; Kozaka K; Kaneko S
    BMC Gastroenterol; 2019 Dec; 19(1):217. PubMed ID: 31842768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study.
    Noronha Ferreira C; Marinho RT; Cortez-Pinto H; Ferreira P; Dias MS; Vasconcelos M; Alexandrino P; Serejo F; Pedro AJ; Gonçalves A; Palma S; Leite I; Reis D; Damião F; Valente A; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Liver Int; 2019 Aug; 39(8):1459-1467. PubMed ID: 31021512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of surgical procedures on the occurrence and development of postoperative portal vein thrombosis in patients with cirrhosis complicated by portal hypertension.
    Sun L; Zhou H; Gu L; Jiang C; Liu Y; Xu Q
    Int J Surg; 2015 Apr; 16(Pt A):31-35. PubMed ID: 25701619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis.
    Suda T; Takatori H; Hayashi T; Horii R; Nio K; Terashima T; Iida N; Kitahara M; Shimakami T; Arai K; Yamashita T; Yamashita T; Mizukoshi E; Honda M; Okumura K; Kozaka K; Kaneko S
    Life (Basel); 2020 Sep; 10(9):. PubMed ID: 32899804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis.
    Naeshiro N; Aikata H; Hyogo H; Kan H; Fujino H; Kobayashi T; Fukuhara T; Honda Y; Nakahara T; Ohno A; Miyaki D; Murakami E; Kawaoka T; Tsuge M; Hiraga N; Hiramatsu A; Imamura M; Kawakami Y; Ochi H; Chayama K
    Hepatol Res; 2015 Jun; 45(6):656-62. PubMed ID: 25088236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impact of Portal Vein Thrombosis on the Prognosis of Patients With Cirrhosis: A Retrospective Propensity-Score Matched Study.
    Chen Z; Ran T; Cao H; Xu F; Zhou ZH; He S
    Front Med (Lausanne); 2021; 8():685944. PubMed ID: 34262917
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis.
    Kukla M; Waluga M; Żorniak M; Berdowska A; Wosiewicz P; Sawczyn T; Bułdak RJ; Ochman M; Ziora K; Krzemiński T; Hartleb M
    World J Gastroenterol; 2017 Apr; 23(14):2613-2624. PubMed ID: 28465646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis.
    Chen H; Qi X; He C; Yin Z; Fan D; Han G
    Thromb Res; 2013 Feb; 131(2):173-7. PubMed ID: 23157737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients.
    Khoury T; Massarwa M; Hazou W; Daher S; Hakimian D; Benson AA; Ashqar T; Mahamid M; Yaari S
    J Gastrointest Cancer; 2019 Dec; 50(4):759-762. PubMed ID: 30043228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.